Related Experiment Videos
The cardiovascular toxicity of antidepressants
1Charterhouse Clinical Research Unit, London, England.
International Clinical Psychopharmacology
|November 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A microdose study of ¹⁴C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung.
European journal of clinical pharmacology·2013
Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitor.
Journal of psychopharmacology (Oxford, England)·2012
Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men.
International journal of clinical pharmacology and therapeutics·2004
Safety, tolerability and pharmacokinetics of subcutaneous A6, an 8-amino acid peptide with anti-angiogenic properties, in healthy men.
International journal of clinical pharmacology and therapeutics·2004
Lithium and GLP-1-based therapies in bipolar disorder: an emerging pharmacovigilance signal and monitoring considerations.
International clinical psychopharmacology·2026
Effectiveness and safety of long-acting aripiprazole 960 mg: preliminary findings from a prospective real-world observational study.
International clinical psychopharmacology·2026
Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.
International clinical psychopharmacology·2026
Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.
International clinical psychopharmacology·2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
International clinical psychopharmacology·2026
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.
International clinical psychopharmacology·2026